Laparoscopic MyomectomyPCV、VCV、PRVCNCT06665061
Effects of Different Ventilation Modes on Airway Pressure and Intracranial Pressure in Patients in the Trendelenburg Position
A study testing PCV, VCV and PRVC in people with Laparoscopic Myomectomy, run by Inner Mongolia Baogang Hospital at 1 site in China.
Trial summary
The goal of this clinical trial is to understand the impact of three different ventilation modes-pressure-controlled ventilation (PCV), volume-controlled ventilation (VCV), and pressure-regulated volume-controlled ventilation (PRVC)-on airway pressure and intracranial pressure in patients undergoing resuscitation… Read more about this study
- Who is it for?
- Ages 22 to 77 years, women only
- Conditions the study is for
- Laparoscopic Myomectomy
- What is being tested?
- PCV, VCV and PRVC
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteChina
- Study dates
- 1 Feb 2023to 30 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 to 77 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ●The patients had an ASA classification of I-III.
Who cannot join
- allergy to the anesthetic drugs
- liver cirrhosis
- kidney dysfunction
- cardiopulmonary impairment
- Patients were uncooperative
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Different Ventilation Modes on Airway Pressure and Intracranial Pressure in Patients in the Trendelenburg Position: a Randomized, Double-blind, Controlled Trial
The goal of this clinical trial is to understand the impact of three different ventilation modes-pressure-controlled ventilation (PCV), volume-controlled ventilation (VCV), and pressure-regulated volume-controlled ventilation (PRVC)-on airway pressure and intracranial pressure in patients undergoing resuscitation positioning. It aims to evaluate the effects of these ventilation modes on patients in resuscitation positions. The main questions it seeks to answer are:
Does the PRVC mode more effectively control airway pressure and intracranial pressure in patients undergoing resuscitation positioning? Does it help to reduce the risk of increased intracranial pressure during surgery?
Read the detailed description
2.1. Trial design This single-center, parallel-arm, double-blinded, randomized, noninferiority trial was performed at Inner Mongolia Baogang Hospital, The Third Affiliated Hospital of Inner Mongolia Medical University, China, from January 2022 to June 2024. The study adhered to Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. 2.2. Participants This study enrolled patients aged 27-77 years who underwent elective laparoscopic myomectomy at our institution from February 2023 to August 2024. The patients had an ASA classification of I-III. Patients were excluded if they had an allergy to the anesthetic drugs used in the study, adverse effects to the analgesics included, liver cirrhosis or kidney dysfunction, or cardiopulmonary impairment. Patients were also excluded if they were uncooperative, defined as being unable to undergo clinical assessment. This study was approved by the Medical Ethics Committee of Inner Mongolia Baogang Hospital (2023-MER-106) .
2.3. Randomization and blinding Patients who met the inclusion criteria were randomly assigned to one of three groups (PCV, VCV, or PRVC) in a 1:1:1 ratio using a random number table. The anesthesiologists and surgeons performing the anesthesia and assisting with the surgery were only informed of the mechanical ventilation mode to be used. Patients were unaware of their group assignment because mechanical ventilation was initiated after anesthesia induction when they were unconscious. The anesthetic nurses and doctors evaluating the patients postoperatively were also unaware of the group assignments.
2.4. Anesthetic and analgesic managements Anesthesia was administered according to standardized institutional protocols. Patients received 1.5-2 mg/kg propofol, 1-2 mg/kg rocuronium, and 1-2 μg/kg remifentanil for induction. Anesthesia was maintained with inhaled sevoflurane or desflurane, with the inhaled concentration adjusted based on the electroencephalogram (EEG). Remifentanil was continuously infused at 0.05-0.2 μg/kg/min, adjusting blood pressure and heart rate to within ±20% of baseline values.
Thirty minutes before anesthesia emergence, all patients were administered 30 mg ketorolac tromethamine (Chengdu Dominant Pharmaceuticals Co., Ltd., China), 1 μg/kg fentanyl, and 4 mg tramadol (Jiangsu Hengrui Pharmaceuticals Co., Ltd., China), and a patient-controlled analgesia (PCA) device (Y-G-B3, JIANGSU YaGuang Medical Appliance CO., LTD., China) was initiated. The PCA was set to deliver a bolus dose of 15 μg fentanyl with a 10-minute lockout interval and no basal infusion (1 mg fentanyl and 8 mg tramadol mixed in 100 mL of normal saline solution). Data on PCA usage were collected, including the time and dose of each administration.
If the pain remained intolerable despite these measures, rescue analgesia was administered, including 1 μg/kg fentanyl or 30 mg ketorolac tromethamine IV.
2.5. Interventions Patients in the PCV group underwent mechanical ventilation in PC mode after induction. The ventilator (MAQUET Flow-I, MAQUET Italia S.p.A. Via Gozzano 14, 200 92 Cinisello Balsamo, (MI) Italy) settings were as follows: Adjust inspiratory pressure (Pins) to maintain the end-tidal carbon dioxide concentration (ETCO2) at 4.0-5.0 kPa. The investigators used 0.3 L/min of pure oxygen and air each, with an oxygen concentration of 41%.
Patients in the VCV group underwent mechanical ventilation in VC mode after induction. The ventilator was set with a tidal volume of 6-8 ml/kg, positive end-expiratory pressure (PEEP) at 0 cmH2O, a ratio of inspiration to expiration of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen concentration of 41%.
Patients in the PRVC group underwent mechanical ventilation in PRVC mode after induction. The respiratory parameters were the same as those in group Ⅱ.
2.6. Outcome measures Record the following parameters at five time points: before insufflation (T1), 5 minutes after insufflation (T2), 10 minutes after insufflation (T3), 15 minutes after insufflation (T4), and 20 minutes after insufflation (T5). Esophageal pressure (pleural pressure, PES), mean airway pressure (PAWM), peak airway pressure (PAP), arterial carbon dioxide partial pressure (PaCO2), end-tidal carbon dioxide concentration (ETCO2), tidal volume (TV), mean arterial pressure (MAP; calculated as diastolic pressure + 1/3 pulse pressure), heart rate (HR), and optic nerve sheath diameter (ONSD). Since SpO2 was 100% at all time points for each group with no statistical difference, SpO2 is not included in the table.
Esophageal pressure (PES) was monitored using a Swan-Ganz catheter (Swan-Ganz, Edwards Lifesciences LLC, One Edwrds Way, Irvine, CA USA 92614) connected to a monitor (M8003A, Hewlett-Packard-Str. 2, 71034 Boblingen, Germany). Blood chemistry parameters were monitored using a blood gas analyzer (i-STAT1 Analyzer MN:300-G, Abbott Park, IL 60064 USA). Optic nerve sheath diameter (ONSD) was measured using an ultrasound system (On-platform ultrasound system PX, Vianen, Netherlands).
In the Postanesthetic Care Unit (PACU), record the following: Length of stay in PACU, Mean arterial pressure, Heart rate, Postoperative nausea and vomiting, Pain, Rescue antiemetics, Rescue analgesics, Rescue Sulfentanil dose.
2.7. Sample size The hypothesis of this study is that optic nerve sheath diameter (ONSD) can effectively differentiate between groups of different ventilation modes, with the hypothesis that the area under the ROC curve for ONSD is greater than 0.5. Preliminary experiments showed that the area under the ROC curve for ONSD is 0.7. With α=0.05 (one-tailed), β=0.1, and an equal ratio of 1:1:1 between groups, the sample size was estimated using n=Δ2/σ2(zα/2+zβ)2 [11,12]. It was found that at least 25 patients were needed per group. Considering a 20% dropout rate, the study included 30 patients in the PCV group, 30 in the VCV group, and 30 in the PRVC group.
2.8. Statistical analysis The sample size was estimated using the "Diagnostic Test (ROC)" - "Test for One Sample Sensitivity and Specificity" module in PASS 11 software. Data are presented as mean (standard deviation), frequency (%), or median (interquartile range). All statistical analyses were performed using GraphPad Prism version 10.2.3.The Kolmogorov-Smirnov test was performed to investigate the normality of the distribution of continuous variables. An independent t test or Mann-Whitney U test was performed to compare continuous variables, as appropriate. The x2 test or Fisher's exact was performed to compare categorical variables. Repeated-measures analysis of variance was performed to compare changes in some variables over time. Statistical significance was set at P value <0.05.
- Conditions
- Laparoscopic Myomectomy
- Being tested
- PCV, VCV, PRVC
- Keywords
- Trendelenburg Position, pressure-controlled ventilation, volume-controlled ventilation, pressure-regulated volume-controlled ventilation, Optic nerve sheath diameter
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PCVDevice
Patients were randomly assigned to receive PCV mechanical ventilation, with consistent ventilation parameters.
VCVDevice
Patients were randomly assigned to receive VCV mode mechanical ventilation, with consistent ventilation parameters.
PRVCDevice
Patients were randomly assigned to receive PRVC mode mechanical ventilation, with consistent ventilation parameters.
| Study group | Role | What they receive |
|---|---|---|
| PCV | Experimental | After intubation under anesthesia, mechanical ventilation is performed in the pressure control ventilation (PCV) mode. Receives: Device: PCV |
| VCV | Experimental | After intubation under anesthesia, mechanical ventilation is performed in the volume control ventilation (VCV) mode. Receives: Device: VCV |
| PRVC | Experimental | After intubation under anesthesia, mechanical ventilation is performed in the pressure-regulated volume control (PRVC) mode. Receives: Device: PRVC |
What is being measured
The primary outcome is the main question the study is designed to answer.
Average Airway Pressure (PAWM) in the Trendelenburg Position
The normal range for Average Airway Pressure (PAWM) during mechanical ventilation is 5-10 cmH2O. The higher the value, the greater the pressure, and the worse the outcome.
Measured: Measurements will be taken at five specific time points: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.
Optic Nerve Sheath Diameter (ONSD) as a Measure of Intracranial Pressure
Optic Nerve Sheath Diameter (ONSD) is a non-invasive method used to assess increased intracranial pressure through ultrasonographic measurement. The normal range for ONSD is approximately between 3.3mm and 5.2mm, while a value exceeding 5mm is generally considered indicative of possible increased intracranial pressure.
Measured: ONSD measurements will be recorded at the same five time points as PAWM: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.
Secondary outcomes (1)
Hemodynamic Stability as Assessed by Mean Arterial Pressure (MAP) and Heart Rate (HR)
Mean Arterial Pressure (MAP), the normal MAP value for adults is typically between 70 to 105mmHg. A MAP exceeding 105 indicates light anesthesia, while below 70 suggests deep anesthesia. Heart Rate (HR), the standard heart rate range for adults at rest is usually 60 to 100 beats per minute. An HR exceeding 100 indicates light anesthesia, and below 60 suggests deep anesthesia. Deviations of MAP and HR from the normal range are undesirable outcomes.
Measured: MAP and HR will be recorded at the same five time points as PAWM and ONSD: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Oct 2024
- Study start1 Feb 2023
- Primary completion30 Aug 2024
- Study completion30 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Laparoscopic MyomectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- This study enrolled patients aged 27-77 years who underwent elective laparoscopic myomectomy at our institution from February 2023 to August 2024. The patients had an ASA classification of I-III. Patients were excluded if they had an allergy to the anesthetic drugs used in the study, adverse effects to the analgesics included, liver cirrhosis or kidney dysfunction, or cardiopulmonary impairment.
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Inner Mongolia Baogang Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06665061
- Sponsor's protocol ID
- 2023-MER-106
- Other IDs
- No. 2024MS08058, No. 2023wsjkkj120, No. YKD2024LH011
- Acronym
- PCV、VCV、PRVC
- Status last verified
- Oct 2024
- First submitted
- 13 Oct 2024
- Last updated
- 30 Oct 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Yes: Esophageal pressure (pleural pressure, PES), mean airway pressure (PAWM), peak airway pressure (PAP), arterial carbon dioxide partial pressure (PaCO2), end-tidal carbon dioxide concentration (ETCO2), tidal volume (TV), mean arterial pressure (MAP; calculated as diastolic pressure + 1/3 pulse pressure), heart rate (HR), and optic nerve sheath diameter (ONSD).
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Different Ventilation Modes on Airway Pressure and Intracranial Pressure in Patients in the Trendelenburg Position: a Randomized, Double-blind, Controlled Trial
- ClinicalTrials.gov ID
- NCT06665061
- Acronym / sponsor ID
- PCV、VCV、PRVC / 2023-MER-106
- Conditions
- Laparoscopic Myomectomy
- Keywords
- Trendelenburg Position, pressure-controlled ventilation, volume-controlled ventilation, pressure-regulated volume-controlled ventilation, Optic nerve sheath diameter
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Inner Mongolia Baogang HospitalUniversity, hospital or other
- Study start
- 1 Feb 2023 (actual)
- Primary completion
- 30 Aug 2024 (actual)
- Study completion
- 30 Aug 2024 (actual)
- First posted
- 30 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to understand the impact of three different ventilation modes-pressure-controlled ventilation (PCV), volume-controlled ventilation (VCV), and pressure-regulated volume-controlled ventilation (PRVC)-on airway pressure and intracranial pressure in patients undergoing resuscitation positioning. It aims to evaluate the effects of these ventilation modes on patients in resuscitation positions. The main questions it seeks to answer are:
Does the PRVC mode more effectively control airway pressure and intracranial pressure in patients undergoing resuscitation positioning? Does it help to reduce the risk of increased intracranial pressure during surgery?
Detailed description
2.1. Trial design This single-center, parallel-arm, double-blinded, randomized, noninferiority trial was performed at Inner Mongolia Baogang Hospital, The Third Affiliated Hospital of Inner Mongolia Medical University, China, from January 2022 to June 2024. The study adhered to Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. 2.2. Participants This study enrolled patients aged 27-77 years who underwent elective laparoscopic myomectomy at our institution from February 2023 to August 2024. The patients had an ASA classification of I-III. Patients were excluded if they had an allergy to the anesthetic drugs used in the study, adverse effects to the analgesics included, liver cirrhosis or kidney dysfunction, or cardiopulmonary impairment. Patients were also excluded if they were uncooperative, defined as being unable to undergo clinical assessment. This study was approved by the Medical Ethics Committee of Inner Mongolia Baogang Hospital (2023-MER-106) .
2.3. Randomization and blinding Patients who met the inclusion criteria were randomly assigned to one of three groups (PCV, VCV, or PRVC) in a 1:1:1 ratio using a random number table. The anesthesiologists and surgeons performing the anesthesia and assisting with the surgery were only informed of the mechanical ventilation mode to be used. Patients were unaware of their group assignment because mechanical ventilation was initiated after anesthesia induction when they were unconscious. The anesthetic nurses and doctors evaluating the patients postoperatively were also unaware of the group assignments.
2.4. Anesthetic and analgesic managements Anesthesia was administered according to standardized institutional protocols. Patients received 1.5-2 mg/kg propofol, 1-2 mg/kg rocuronium, and 1-2 μg/kg remifentanil for induction. Anesthesia was maintained with inhaled sevoflurane or desflurane, with the inhaled concentration adjusted based on the electroencephalogram (EEG). Remifentanil was continuously infused at 0.05-0.2 μg/kg/min, adjusting blood pressure and heart rate to within ±20% of baseline values.
Thirty minutes before anesthesia emergence, all patients were administered 30 mg ketorolac tromethamine (Chengdu Dominant Pharmaceuticals Co., Ltd., China), 1 μg/kg fentanyl, and 4 mg tramadol (Jiangsu Hengrui Pharmaceuticals Co., Ltd., China), and a patient-controlled analgesia (PCA) device (Y-G-B3, JIANGSU YaGuang Medical Appliance CO., LTD., China) was initiated. The PCA was set to deliver a bolus dose of 15 μg fentanyl with a 10-minute lockout interval and no basal infusion (1 mg fentanyl and 8 mg tramadol mixed in 100 mL of normal saline solution). Data on PCA usage were collected, including the time and dose of each administration.
If the pain remained intolerable despite these measures, rescue analgesia was administered, including 1 μg/kg fentanyl or 30 mg ketorolac tromethamine IV.
2.5. Interventions Patients in the PCV group underwent mechanical ventilation in PC mode after induction. The ventilator (MAQUET Flow-I, MAQUET Italia S.p.A. Via Gozzano 14, 200 92 Cinisello Balsamo, (MI) Italy) settings were as follows: Adjust inspiratory pressure (Pins) to maintain the end-tidal carbon dioxide concentration (ETCO2) at 4.0-5.0 kPa. The investigators used 0.3 L/min of pure oxygen and air each, with an oxygen concentration of 41%.
Patients in the VCV group underwent mechanical ventilation in VC mode after induction. The ventilator was set with a tidal volume of 6-8 ml/kg, positive end-expiratory pressure (PEEP) at 0 cmH2O, a ratio of inspiration to expiration of 1:2, a respiratory rate of 16 breaths per minute, and an oxygen concentration of 41%.
Patients in the PRVC group underwent mechanical ventilation in PRVC mode after induction. The respiratory parameters were the same as those in group Ⅱ.
2.6. Outcome measures Record the following parameters at five time points: before insufflation (T1), 5 minutes after insufflation (T2), 10 minutes after insufflation (T3), 15 minutes after insufflation (T4), and 20 minutes after insufflation (T5). Esophageal pressure (pleural pressure, PES), mean airway pressure (PAWM), peak airway pressure (PAP), arterial carbon dioxide partial pressure (PaCO2), end-tidal carbon dioxide concentration (ETCO2), tidal volume (TV), mean arterial pressure (MAP; calculated as diastolic pressure + 1/3 pulse pressure), heart rate (HR), and optic nerve sheath diameter (ONSD). Since SpO2 was 100% at all time points for each group with no statistical difference, SpO2 is not included in the table.
Esophageal pressure (PES) was monitored using a Swan-Ganz catheter (Swan-Ganz, Edwards Lifesciences LLC, One Edwrds Way, Irvine, CA USA 92614) connected to a monitor (M8003A, Hewlett-Packard-Str. 2, 71034 Boblingen, Germany). Blood chemistry parameters were monitored using a blood gas analyzer (i-STAT1 Analyzer MN:300-G, Abbott Park, IL 60064 USA). Optic nerve sheath diameter (ONSD) was measured using an ultrasound system (On-platform ultrasound system PX, Vianen, Netherlands).
In the Postanesthetic Care Unit (PACU), record the following: Length of stay in PACU, Mean arterial pressure, Heart rate, Postoperative nausea and vomiting, Pain, Rescue antiemetics, Rescue analgesics, Rescue Sulfentanil dose.
2.7. Sample size The hypothesis of this study is that optic nerve sheath diameter (ONSD) can effectively differentiate between groups of different ventilation modes, with the hypothesis that the area under the ROC curve for ONSD is greater than 0.5. Preliminary experiments showed that the area under the ROC curve for ONSD is 0.7. With α=0.05 (one-tailed), β=0.1, and an equal ratio of 1:1:1 between groups, the sample size was estimated using n=Δ2/σ2(zα/2+zβ)2 [11,12]. It was found that at least 25 patients were needed per group. Considering a 20% dropout rate, the study included 30 patients in the PCV group, 30 in the VCV group, and 30 in the PRVC group.
2.8. Statistical analysis The sample size was estimated using the "Diagnostic Test (ROC)" - "Test for One Sample Sensitivity and Specificity" module in PASS 11 software. Data are presented as mean (standard deviation), frequency (%), or median (interquartile range). All statistical analyses were performed using GraphPad Prism version 10.2.3.The Kolmogorov-Smirnov test was performed to investigate the normality of the distribution of continuous variables. An independent t test or Mann-Whitney U test was performed to compare continuous variables, as appropriate. The x2 test or Fisher's exact was performed to compare categorical variables. Repeated-measures analysis of variance was performed to compare changes in some variables over time. Statistical significance was set at P value <0.05.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 3
- Model description
- This study enrolled patients aged 27-77 years who underwent elective laparoscopic myomectomy at our institution from February 2023 to August 2024. The patients had an ASA classification of I-III. Patients were excluded if they had an allergy to the anesthetic drugs used in the study, adverse effects to the analgesics included, liver cirrhosis or kidney dysfunction, or cardiopulmonary impairment.
| Arm | Type | Receives |
|---|---|---|
| PCV | Experimental | Device: PCVAfter intubation under anesthesia, mechanical ventilation is performed in the pressure control ventilation (PCV) mode. |
| VCV | Experimental | Device: VCVAfter intubation under anesthesia, mechanical ventilation is performed in the volume control ventilation (VCV) mode. |
| PRVC | Experimental | Device: PRVCAfter intubation under anesthesia, mechanical ventilation is performed in the pressure-regulated volume control (PRVC) mode. |
Who may qualify
- Ages
- 22 to 77 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- ●The patients had an ASA classification of I-III.
Key exclusion criteria (5 listed)
- allergy to the anesthetic drugs
- liver cirrhosis
- kidney dysfunction
- cardiopulmonary impairment
- Patients were uncooperative
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PCVPatients were randomly assigned to receive PCV mechanical ventilation, with consistent ventilation parameters. | Device | PCV |
| VCVPatients were randomly assigned to receive VCV mode mechanical ventilation, with consistent ventilation parameters. | Device | VCV |
| PRVCPatients were randomly assigned to receive PRVC mode mechanical ventilation, with consistent ventilation parameters. | Device | PRVC |
Primary outcome
Average Airway Pressure (PAWM) in the Trendelenburg Position
Time frame: Measurements will be taken at five specific time points: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.
The normal range for Average Airway Pressure (PAWM) during mechanical ventilation is 5-10 cmH2O. The higher the value, the greater the pressure, and the worse the outcome.
Optic Nerve Sheath Diameter (ONSD) as a Measure of Intracranial Pressure
Time frame: ONSD measurements will be recorded at the same five time points as PAWM: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.
Optic Nerve Sheath Diameter (ONSD) is a non-invasive method used to assess increased intracranial pressure through ultrasonographic measurement. The normal range for ONSD is approximately between 3.3mm and 5.2mm, while a value exceeding 5mm is generally considered indicative of possible increased intracranial pressure.
1 secondary outcome
Hemodynamic Stability as Assessed by Mean Arterial Pressure (MAP) and Heart Rate (HR)
Time frame: MAP and HR will be recorded at the same five time points as PAWM and ONSD: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2024.
- Individual participant dataSharing planned: Yes. Esophageal pressure (pleural pressure, PES), mean airway pressure (PAWM), peak airway pressure (PAP), arterial carbon dioxide partial pressure (PaCO2), end-tidal carbon dioxide concentration (ETCO2), tidal volume (TV), mean arterial pressure (MAP; calculated as diastolic pressure + 1/3 pulse pressure), heart rate (HR), and optic nerve sheath diameter (ONSD).
Related trials for Laparoscopic Myomectomy
Not yet recruiting
LapBox® Manual Containment System
Surgery
RecruitingPhase 4
QL Block in Laparoscopic Myomectomy
Postoperative Pain, Fibroid Uterus
Recruiting
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Myoma
RecruitingObservational study
Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery
to Determine Whether Patient Satisfaction With Postoperative Telehealth Follow-up is Non-inferior to In-person Clinic Visits
Recruiting
Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy
Laparoscopic Myomectomy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing PCV, VCV and PRVC in people with Laparoscopic Myomectomy, run by Inner Mongolia Baogang Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Average Airway Pressure (PAWM) in the Trendelenburg Position (time frame: Measurements will be taken at five specific time points: before and after pneumoperitoneum at 5, 10, 15, and 20 minutes.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2024.